EDGAR Filing Documents for 0001144204-08-006780

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-08-006780

Filing Date

2008-02-07

Accepted

2008-02-07 16:02:18

Documents

Period of Report

2008-02-07

Document Format Files

Seq	Description	Document	Type	Size
1		v102312_6k.htm	6-K	20771
2	GRAPHIC	v102312_logo.jpg	GRAPHIC	2936
	Complete submission text file	0001144204-08-006780.txt		26356

Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989

Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440

XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 08585258
SIC: 2834 Pharmaceutical Preparations